Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 5:12 AM
Ignite Modification Date:
2025-12-26 @ 4:17 AM
NCT ID:
NCT02520427
Group ID:
EG025
Title:
Group 4: Tocilizumab, Dexamethasone and AMG 330
Description:
Participants with R/R AML received tocilizumab 8 mg/kg IV infusion and dexamethsone 8 mg IV infusion in combination with AMG 330. Participants received AMG 330 at initial daily step doses of 10 µg/day for 2 days, 60 µg/day for 3 days and 240 µg/day for 9 days for a total of a 14 day cIV. Participants received tocilizumab on Day 1, 1 hour before the 1st dose of AMG 330 of each cycle. Participants received dexamethasone 1 hour before AMG 330 dose.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
1
Other Number Affected:
1
Other Number At Risk:
1
Study:
NCT02520427
Results Section:
NCT02520427
Adverse Events Module:
NCT02520427